参考文献/References:
[1] Tuomilehto J,Lindstr?觟m J,Eriksson JG,et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance[J]. N Engl J Med,2011,344 （18）：1343-1350.
[2] Knowler WC,Barrett-Connor E,Fowler SE,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin[J]. N Engl J Med,2002,346（6）：393-403.
[3] Anderson JW,Kendall CW,Jenkins DJ.Importance of weight management in type 2 diabetes：review with meta-analysis of clinical studies[J]. J Am Coll Nutr,2003,22（5）：331-339.
[4] Capstick F,Brooks BA,Burns CM,et al. Very low calorie diet （VLCD）：a useful alternative in the treatment of the obese NIDDM patient[J]. Diabetes Res Clin Pract,1997,36（2）：105-111.
[5] Lim EL,Hollingsworth KG,Aribisala BS,et al. Reversal of type 2 diabetes：normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol[J]. Diabetologia,2011,54（10）：2506-2514.
[6] Unick JL,Beavers D,Bond DS,et al. The long-term effective-ness of a lifestyle intervention in severely obese individuals[J]. Am J Med,2013,126（3）：236-242.e1-e2.
[7] Dhindsa P,Scott AR,Donnelly R.Metabolic and cardiovascular effects of very-low-calorie diet therapy in obese patients with type 2 diabetes in secondary failure：outcomes after 1 year[J]. Diabet Med,2003,20（4）：319-324.
[8] Jazet IM,de Craen AJ,van Schie EM,et al. Sustained beneficial metabolic effects 18 months after a 30-day very low calorie diet in severely obese,insulin-treated patients with type 2 diabetes[J]. Diabetes Res Clin Pract,2007,77（1）：70-76.
[9] Willi SM,Martin K,Datko FM,et al. Treatment of type 2 diabetes in childhood using a very-low-calorie diet[J]. Diabetes Care,2004,27（2）：348-353.
[10] Espeland MA,Rejeski WJ,West DS,et al. Intensive weight loss intervention in older individuals：results from the Action for Health in Diabetes Type 2 diabetes mellitus trial[J]. J Am Geriatr Soc,2013,61（6）：912-922.
[11] Malandrucco I,Pasqualetti P,Giordani I,et al. Very-low-calorie diet：a quick therapeutic tool to improve beta cell function in morbidly obese patients with type 2 diabetes[J]. Am J Clin Nutr,2012,95（3）：609-613.
[12] Bergman BC,Cornier MA,Horton TJ,et al.Effects of fasting on insulin action and glucose kinetics in lean and obese men and women[J]. Am J Physiol Endocrinol Metab,2007,293（4）： E1103-E1111.
[13] Shimazu T,Hirschey MD,Newman J,et al. Suppression of oxidative stress by β-hydroxybutyrate,an endogenous histone deacetylase inhibitor[J]. Science,2013,339（6116）：211-214.
[14] Soeters MR,Lammers NM,Dubbelhuis PF,et al. Intermittent fasting does not affect whole-body glucose,lipid,or protein metabolism[J]. Am J Clin Nutr,2009,90（5）：1244-1251.
[15] Kume S,Uzu T,Kashiwagi A,et al. SIRT1,a calorie restriction mimetic,in a new therapeutic approach for type 2 diabetes mellitus and diabetic vascular complications[J]. Endocr Metab Immune Disord Drug Targets,2010,10（1）：16-24.
[16] Sumithran P,Proietto J. Ketogenic diets for weight loss：A review of their principles,safety and efficacy[J]. Obes Res Clin Pract,2008,2（1）：I-II.
[17] Svendsen PF,Jensen FK,Holst JJ,et al. The effect of a very low calorie diet on insulin sensitivity,beta cell function,insulin clearance,incretin hormone secretion,androgen levels and body composition in obese young women[J]. Scand J Clin Lab Invest, 2012,72（5）：410-419.
[18] Yki-J?覿rvinen H. Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance：human data[J]. Curr Opin Clin Nutr Metab Care,2010,13（6）：709-714.
[19] Varady KA,Hellerstein MK. Alternate-day fasting and chronic disease prevention：a review of human and animal trials[J]. Am J Clin Nutr,2007,86（1）：7-13.
[20] Speakman JR,Mitchell SE. Caloric restriction[J]. Mol Aspects Med,2011,32（3）：159-221.
[21] Qiao L,Lee B,Kinney B,et al. Energy intake and adiponectin gene expression[J]. Am J Physiol Endocrinol Metab,2011,300（5）：E809-E816.
[22] Baker S,Jerums G,Proietto J,et al. Effects and clinical poten-tial of very-low-calorie diets（VLCDs）in type 2 diabetes[J]. Diabetes Res Clin Pract,2009,85（3）：235-242.
相似文献/References:
[1]曾静波,王姮.2型糖尿病与自身免疫反应[J].国际内分泌代谢杂志,2007,(04):259.
[2]朱素君,谢锦桃,刘军,等.二甲双胍：2型糖尿病治疗的基础药[J].国际内分泌代谢杂志,2007,(04):280.
[3]刘艳清 易秋艳 邵加庆.肠道菌群与肥胖和糖尿病的关系[J].国际内分泌代谢杂志,2015,(01):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
Liu Yanqing,Yi Qiuyan,Shao Jiaqing..Relationship between gut microbiota, obesity and diabetes[J].International Journal of Endocrinology and Metabolism,2015,(02):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
[4]姚旻 赵爱源 张宏.肠道菌群与2型糖尿病[J].国际内分泌代谢杂志,2015,(01):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
Yao Min*,Zhao Aiyuan,Zhang Hong..Relationship between gut microbiota and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(02):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
[5]赵丽娟,徐宽枫,杨涛,等.SLC30A8和PTPRD基因多态性与南京地区中老年人群2型糖尿病的相关性研究[J].国际内分泌代谢杂志,2015,(03):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
Zhao Lijuan*,Xu Kuanfeng,Yang Tao,et al.Relationship between SLC30A8 and PTPRD gene polymorphisms and type 2 diabetes in middle aged and elderly people in Nanjing area[J].International Journal of Endocrinology and Metabolism,2015,(02):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
[6]王洁,何媛,于珮.糖尿病肾病的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
Wang Jie*,He Yuan,Yu Pei..Risk factors of diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(02):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
[7]刘帅,张萍,方毅,等.2型糖尿病合并无症状冠状动脉钙化的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
Liu Shuai*,Zhang Ping,Fang Yi,et al.Analysis of the risk factors related with asymptomatic coronary calcification for type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(02):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
[8]徐庆海,马颖,李铁马.2型糖尿病患者高甘油三酯血症-腰围表型与甲状腺功能异常的关系[J].国际内分泌代谢杂志,2015,(04):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
Xu Qinghai,Ma Ying,Li Tiema..Association of hypertriglyceridaemic-waist phenotype with thyroid dysfunction in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(02):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
[9]潘道延,沈洁,朱筱,等.利格列汀对2型糖尿病大鼠代谢性内毒素血症的影响[J].国际内分泌代谢杂志,2015,(04):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
Pan Daoyan,Shen Jie,Zhu Xiao,et al.Effects of linagliptin on metabolic endotoxemia in type 2 diabetic rats[J].International Journal of Endocrinology and Metabolism,2015,(02):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
[10]黄桥,白洁,杜洪泉.一种新的脂肪细胞因子——cartonectin[J].国际内分泌代谢杂志,2015,(04):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
Huang Qiao*,Bai Jie,Du Hongquan..A novel adipokine--cartonectin[J].International Journal of Endocrinology and Metabolism,2015,(02):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
[11]孙洪平,陈国芳,曹雯,等.限食疗法对心血管疾病预防及治疗的研究进展[J].国际内分泌代谢杂志,2014,(03):172.[doi:10.3760/cma.j.issn.1673-4157.2014.03.008]
Sun Hongping,Chen Guofang,Cao Wen,et al.Effects of calorie restriction on prevention and treatment of cardiovascular diseases[J].International Journal of Endocrinology and Metabolism,2014,(02):172.[doi:10.3760/cma.j.issn.1673-4157.2014.03.008]